Hyphens Pharma International Limited (SGX:1J5)
Singapore
· Delayed Price · Currency is SGD 0.2900
-0.0200 (-6.45%)
At close: Aug 15, 2025
SGXC:1J5 Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 90 | 88 | 88 | 103 | 93 | 95 | Upgrade
|
| Market Cap Growth | 16.07% | -0.10% | -14.81% | 11.67% | -2.12% | 50.00% | Upgrade
|
| Enterprise Value | 73 | 81 | 61 | 82 | 66 | 75 | Upgrade
|
| Last Close Price | 0.29 | 0.27 | 0.26 | 0.26 | 0.23 | 0.24 | Upgrade
|
| PE Ratio | 14.18 | 8.64 | 10.29 | 9.11 | 13.53 | 15.36 | Upgrade
|
| Forward PE | 7.63 | 7.75 | 8.88 | 9.49 | 12.88 | 14.58 | Upgrade
|
| PS Ratio | 0.48 | 0.45 | 0.52 | 0.64 | 0.74 | 0.78 | Upgrade
|
| PB Ratio | 1.32 | 1.18 | 1.34 | 1.47 | 1.69 | 2.01 | Upgrade
|
| P/TBV Ratio | 2.19 | 1.90 | 2.24 | 2.07 | 2.54 | 2.41 | Upgrade
|
| P/FCF Ratio | 13.10 | - | 16.50 | 6.34 | 17.36 | 25.18 | Upgrade
|
| P/OCF Ratio | 11.56 | 1467.17 | 15.61 | 6.13 | 15.34 | 22.91 | Upgrade
|
| PEG Ratio | 2.38 | 1.62 | 1.62 | 1.62 | 1.62 | 1.54 | Upgrade
|
| EV/Sales Ratio | 0.40 | 0.42 | 0.36 | 0.50 | 0.52 | 0.62 | Upgrade
|
| EV/EBITDA Ratio | 4.85 | 5.45 | 4.83 | 5.08 | 7.24 | 12.18 | Upgrade
|
| EV/EBIT Ratio | 6.02 | 6.08 | 5.54 | 5.65 | 8.45 | 15.27 | Upgrade
|
| EV/FCF Ratio | 10.72 | - | 11.43 | 5.00 | 12.34 | 20.00 | Upgrade
|
| Debt / Equity Ratio | - | 0.19 | 0.10 | 0.08 | 0.15 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.86 | 0.49 | 0.33 | 0.82 | 0.71 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.28 | 0.35 | 1.53 | 1.32 | Upgrade
|
| Asset Turnover | 1.46 | 1.52 | 1.45 | 1.52 | 1.39 | 1.50 | Upgrade
|
| Inventory Turnover | 3.83 | 4.24 | 4.68 | 4.30 | 3.72 | 5.61 | Upgrade
|
| Quick Ratio | 1.22 | 1.18 | 1.30 | 1.67 | 1.12 | 1.67 | Upgrade
|
| Current Ratio | 1.80 | 1.84 | 1.87 | 2.24 | 1.74 | 2.27 | Upgrade
|
| Return on Equity (ROE) | 10.17% | 15.47% | 12.61% | 18.25% | 13.44% | 13.51% | Upgrade
|
| Return on Assets (ROA) | 6.01% | 6.50% | 5.85% | 8.45% | 5.39% | 3.81% | Upgrade
|
| Return on Capital (ROIC) | 10.53% | 10.34% | 9.26% | 13.01% | 8.46% | 6.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.40% | 17.10% | 15.40% | 19.40% | 13.80% | 9.60% | Upgrade
|
| Earnings Yield | 7.21% | 11.58% | 9.72% | 10.97% | 7.39% | 6.51% | Upgrade
|
| FCF Yield | 7.63% | -1.28% | 6.06% | 15.78% | 5.76% | 3.97% | Upgrade
|
| Dividend Yield | 5.17% | 5.55% | 3.28% | 4.22% | 2.91% | 2.62% | Upgrade
|
| Payout Ratio | 84.83% | 26.05% | 169.97% | 18.23% | 27.21% | 48.74% | Upgrade
|
| Buyback Yield / Dilution | -1.38% | -1.74% | 0.27% | -2.66% | -0.60% | -0.05% | Upgrade
|
| Total Shareholder Return | 3.46% | 3.81% | 3.55% | 1.57% | 2.31% | 2.57% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.